SPY772.30+0.12%QQQ745.45+0.13%BTC/USD84,043.50−0.41%DIA517.72+0.04%GLD393.00−0.10%TLT79.41+0.11%
Benzinga

Zoetis Inc (ZTS) Stock Price, Quote, News & History

ZTSNYSE
Trade with Public
Trade with Public
$71.05
0.781.11%
At close: Sep 25, 5:00 PM EST
$71.00
-0.0478-0.07%
After Hours: 7:29 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipDividendsCompareOptionsStock Report

Zoetis (ZTS) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$70.00
Close
$71.05
Volume / Avg.
4.17M / 5.84M
Day Range
$69.52 - $71.08
52 Wk Range
69.93 - 148.79
Market Cap
$29.34B
P/E Ratio
11.46
Dividend Yield
3.02%
Exchange
NYSE
RSI
39
Short Interest
4.76%
Days to Cover
3.83

Recent Zoetis Inc News

5 Stock Picks Last Week From Wall Street's Most Accurate Analysts

U.S. stocks close higher on Friday, with Nasdaq up 300 points and S&P 500 at record high. Benzinga's Analyst Ratings API can aid in stock picks.
Avi Kapoor

Zoetis Sees Softer Pet Health Demand, But Adapting Commercial Strategy to Navigate Headwinds

Zoetis beat second-quarter earnings estimates but missed on revenue, cut 2026 guidance and cited weaker pet health demand and pricing pressure.
Vandana Singh

Michael Burry Expands Bets Against Nvidia, Micron— and Is Now Buying Lululemon and DraftKings

Michael Burry expands short positions against Nvidia and AI, while piling into de-risked value stocks like Lululemon and DraftKings.
Rishabh Mishra

Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia

The Australian agency is conducting a Phase 2 assessment of Zoetis' $160 million acquisition of Neogen's genomics unit due to competition concerns.
Vandana Singh

Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick

Cramer says Zoetis has issues. Prefers this stock in animal health industry. Energy Transfer is in a good position.
Avi Kapoor
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
2.84B
Investing Cash Flow (TTM)
-720.00M
Financing Cash Flow (TTM)
-2.28B
Free Cash Flow (TTM)
2.32B
Capital Expenditure (TTM)
-524.00M
Net Change in Cash (TTM)
-162.00M

Analyst Trends and Forecast

1
1
Apr
2
1
May
1
Jun
2
2
Jul
4
3
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.4
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$36.60B
PE Ratio (TTM)
11.46
PE Ratio (FWD)
11.76
PEG Ratio (TTM)
6.54
PS Ratio (TTM)
3.18
PB Ratio (TTM)
9.22
Earnings Yield % (TTM)
8.72%
Earnings Yield % (FWD)
8.50%
EV / EBITDA (TTM)
9.11
Price / EBITDA (TTM)
7.53
Price / Free Cash Flow (TTM)
13.06
Book Value / Share
$7.62

Company Debt

Total Debt
$9.05B
LT Debt
$9.05B
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$1.47B
Debt to Equity
2.93
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$70.00
Close
$71.05
Volume / Avg.
4.17M / 5.84M
Day Range
$69.52 - $71.08
52 Wk Range
69.93 - 148.79
Market Cap
$29.34B
P/E Ratio
11.46
Dividend Yield
3.02%
Exchange
NYSE
RSI
39
Short Interest
4.76%
Days to Cover
3.83

About

Sector
Health Care
Industry
Pharmaceuticals
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (do...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Zoetis (ZTS) stock?

A

You can purchase shares of Zoetis (NYSE:ZTS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Zoetis (ZTS) competitors?

Q

What is the forecast, or price target, for Zoetis (ZTS) stock?

A

Zoetis has a consensus price target of $137.78.

Q

What is the current price for Zoetis (ZTS)?

A

The stock price for Zoetis (NYSE: ZTS) is $71.0022 last updated September 25, 2026 at 7:29 PM EDT.

Q

Does Zoetis (ZTS) pay a dividend?

A

There are no upcoming dividends for Zoetis.

Q

When is Zoetis (NYSE:ZTS) reporting earnings?

A

Zoetis does not have any upcoming earnings scheduled.

Q

Is Zoetis (ZTS) going to split?

A

There is no upcoming split for Zoetis.

Q

What sector and industry does Zoetis (ZTS) operate in?

A

Zoetis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved